These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 17878114

  • 1. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
    Patel HM, Suhagia BN, Shah SA, Rathod IS, Parmar VK.
    Acta Pharm; 2007 Sep; 57(3):351-9. PubMed ID: 17878114
    [Abstract] [Full Text] [Related]

  • 2. Development and pharmacological evaluation of cyclodextrin complexes of etoricoxib.
    Singh I, Kumar P, Pahuja S, Tung V, Arora S.
    Acta Pol Pharm; 2011 Sep; 68(2):279-84. PubMed ID: 21485302
    [Abstract] [Full Text] [Related]

  • 3. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
    Shah M, Karekar P, Sancheti P, Vyas V, Pore Y.
    Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
    [Abstract] [Full Text] [Related]

  • 4. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 5. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M, Maestrelli F, Bragagni M, Mura P.
    J Pharm Biomed Anal; 2010 May 01; 52(1):9-18. PubMed ID: 20004541
    [Abstract] [Full Text] [Related]

  • 6. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr 01; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 7. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
    Semcheddine F, Guissi Nel I, Liu X, Wu Z, Wang B.
    AAPS PharmSciTech; 2015 Jun 01; 16(3):704-15. PubMed ID: 25511809
    [Abstract] [Full Text] [Related]

  • 8. Physicochemical investigation of the solid dispersion systems of etoricoxib with poloxamer 188.
    Karekar P, Vyas V, Shah M, Sancheti P, Pore Y.
    Pharm Dev Technol; 2009 Jun 01; 14(4):373-9. PubMed ID: 19552551
    [Abstract] [Full Text] [Related]

  • 9. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N, Ordu S.
    Drug Dev Ind Pharm; 1998 Jan 01; 24(1):19-25. PubMed ID: 15605593
    [Abstract] [Full Text] [Related]

  • 10. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P.
    Drug Dev Ind Pharm; 2005 Aug 01; 31(7):697-707. PubMed ID: 16207617
    [Abstract] [Full Text] [Related]

  • 11. Influence of β-cyclodextrin on the Properties of Norfloxacin Form A.
    Chierentin L, Garnero C, Chattah AK, Delvadia P, Karnes T, Longhi MR, Salgado HR.
    AAPS PharmSciTech; 2015 Jun 01; 16(3):683-91. PubMed ID: 25511811
    [Abstract] [Full Text] [Related]

  • 12. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
    Figueiras A, Carvalho RA, Ribeiro L, Torres-Labandeira JJ, Veiga FJ.
    Eur J Pharm Biopharm; 2007 Sep 01; 67(2):531-9. PubMed ID: 17451924
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of quercetin and rutin cyclodextrin inclusion complexes.
    Sri KV, Kondaiah A, Ratna JV, Annapurna A.
    Drug Dev Ind Pharm; 2007 Mar 01; 33(3):245-53. PubMed ID: 17454057
    [Abstract] [Full Text] [Related]

  • 14. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr 01; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
    Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ.
    Eur J Pharm Biopharm; 2007 Jun 01; 66(3):413-21. PubMed ID: 17240129
    [Abstract] [Full Text] [Related]

  • 16. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
    Semalty M, Panchpuri M, Singh D, Semalty A.
    Curr Drug Discov Technol; 2014 Jun 01; 11(2):154-61. PubMed ID: 24188445
    [Abstract] [Full Text] [Related]

  • 17. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
    Sbârcea L, Udrescu L, Drăgan L, Trandafirescu C, Szabadai Z, Bojiţă M.
    Pharmazie; 2011 Aug 01; 66(8):584-9. PubMed ID: 21901980
    [Abstract] [Full Text] [Related]

  • 18. Preparation and characterization of mosapride citrate inclusion complexes with natural and synthetic cyclodextrins.
    Ali AA, Sayed OM.
    Pharm Dev Technol; 2013 Aug 01; 18(5):1042-50. PubMed ID: 22206481
    [Abstract] [Full Text] [Related]

  • 19. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR, Nanda A, Chadha R, Goel H.
    Acta Pol Pharm; 2011 Aug 01; 68(4):585-92. PubMed ID: 21796941
    [Abstract] [Full Text] [Related]

  • 20. Influence of the preparation method on the physical-chemical properties of ketoprofen-cyclodextrin-phosphatidylcholine ternary systems.
    Cirri M, Maestrelli F, Mennini N, Mura P.
    J Pharm Biomed Anal; 2009 Dec 05; 50(5):690-4. PubMed ID: 19097721
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.